View Cart (0 items)

Pharmaceutical

Chinese pharma industry eyes international opportunities

Big Chinese pharmaceutical companies are no longer happy playing only in their local markets. Several of them are hoping to establish a notable presence on the U.S. market, mostly through partnerships with international industry giants.
Read More

U.S. pharmaceutical companies granted easier access to EU market

The United States is now considered a "listed country" by the European Commission, which means that U.S. companies don’t need an FDA export certificate before shipping certain pharmaceutical products to the European Union.
Read More

AstraZeneca to build new HQ, research center in Cambridge, UK

AstraZeneca is investing about £330 million ($515.6 million) in its new building, which will host a global R&D center.
Read More

Bill passed to fight counterfeit drugs

The United States has passed a bill intended to set up a national system for tracking pharmaceutical products through the supply chain to prevent counterfeit medicines from accessing the market.
Read More

FDA warns of counterfeit botox

The U.S. FDA has warned in recent days that fraudulent versions of Allergan's drug Botox are being distributed here in the U.S. The agency called for healthcare practitioners and the general public to exercise caution when dealing with the drug.
Read More

The romance of stainless steel explicated at Interphex

When this editor was stationed in the engineering department some years ago, the mechanical engineers, and especially the engineering director, used to get a bit dreamy-eyed when the subject turned to stainless steel.


Read More

Compounding pharmacy issues recall over sterility doubts

Florida-based Balanced Solutions Compounding Pharmacy has issued a voluntary recall of all lots of its sterile non-expired drug products sold nationwide following concerns that their sterility may be compromised.
Read More

Thermo Fisher Scientific to buy Life Technologies Corp. for $13.6 billion

According to Thermo Fisher Scientific, the transaction "will create an unrivaled leader in serving research, speciality diagnostics and applied markets."
Read More

AstraZeneca's asthma treatment drug patent found invalid

Drug manufacturer AstraZeneca has lost a legal battle in the United States after a court ruling that found its patent for a childhood asthma treatment invalid.
Read More

Largest drug companies profited more than $700 billion in decade, analysis estimates

The 11 largest drug companies took $711.4 billion in profits over the 10 years ending in 2012, according to an analysis of corporate filings by Health Care for America Now (HCAN).
Read More